Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FK2TD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,370
Award facts
- Contract value 100% obligated
- $3,369.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,369.92 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adults aged 18 years and older, reflecting the agency's continued procurement of critical immunization products for military and defense healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen serves as a critical vendor in the Defense Health Agency's medical supply chain, providing a comprehensive portfolio of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military personnel and veteran healthcare programs globally. The company's prime indefinite delivery vehicle enables flexible fulfillment of evolving federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FK2TD?
SPE2DB26FK2TD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FK2TD worth?
The government has obligated $3,370 on SPE2DB26FK2TD.
Is contract SPE2DB26FK2TD an order under another contract?
Yes. SPE2DB26FK2TD is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB26FK2TD competed?
The extent of competition for SPE2DB26FK2TD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award